1. Hypoxia-inducible factor–1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma
   Matthew Womeldorff et al, 2014, Neurosurgical Focus CrossRef
2. Advances in HSP27 and HSP90-targeting strategies for glioblastoma
   Randy van Ommeren et al, 2016, Journal of Neuro-Oncology CrossRef
3. Heat Shock Proteins in Glioblastoma Biology: Where Do We Stand?
   Rebeca Piatniczka Iglesia et al, 2019, International Journal of Molecular Sciences CrossRef
4. Screening of Multiple Myeloma by Polyclonal Rabbit Anti-Human Plasmacytoma Cell Immunoglobulin
   Bo Mu et al, 2013, PLoS ONE CrossRef
5. Therapeutic Drugs and Natural Products: The Effect of Suppressing Heat Shock Proteins (Hsp) in Brain Tumors
   Elif Mertoğlu et al, 2019, Heat Shock Proteins in Neuroscience CrossRef
6. Hsp27, Hsp60, Hsp70, or Hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells
   Evren Önay Uçar et al, 2023, Biochemical Pharmacology CrossRef
7. SNX-2112, an Hsp90 inhibitor, suppresses cervical cancer cells proliferation, migration, and invasion by inhibiting the Akt/mTOR signaling pathway
   Liang-Shun Fu et al, 2020, Medicinal Chemistry Research CrossRef
8. Indatraline inhibits Rho- and calcium-mediated glioblastoma cell motility and angiogenesis
   Jin-Chul Heo et al, 2014, Biochemical and Biophysical Research Communications CrossRef
9. Molecular profiling of childhood cancer: Biomarkers and novel therapies
   Federica Saletta et al, 2014, BBA Clinical CrossRef
10. MET in glioma: signaling pathways and targeted therapies
    Fangling Cheng et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
11. Systematic Review of Protein Biomarkers of Invasive Behavior in Glioblastoma
    Eli T. Sayegh et al, 2014, Molecular Neurobiology CrossRef
12. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment
    Davide Frumento et al, 2024, International Journal of Molecular Sciences CrossRef